CAMLINFINE · Basic Materials · Specialty Chemicals
Composite scorecard: 10/100 — Quality 19 · Valuation 2 · Momentum 0
| Share price | ₹123.96 |
| Market cap | ₹2,469 Cr |
| P/B ratio | 2.4 |
| ROE | 143.8% |
| ROCE | 3.6% |
| Book value | ₹54.17 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹1,723 Cr | ₹24 Cr | 6.0% |
| 2025 | ₹1,667 Cr | ₹-158 Cr | 13.0% |
| 2024 | ₹1,454 Cr | ₹-105 Cr | 12.0% |
| 2023 | ₹1,682 Cr | ₹40 Cr | 13.0% |
| 2022 | ₹1,412 Cr | ₹60 Cr | 11.0% |
Camlin Fine Sciences Limited, together with its subsidiaries, research, develops, manufactures, and markets specialty chemicals, ingredients, and additive blend products in India and internationally. The company offers shelf-life solutions, which include basic ingredients, such as tert-butylhydroquinone (TBHQ), Butylated Hydroxyanisole (BHA), Butylated Hydroxytoluene (BHT), and Ascorbyl Palmitate (ASP); aroma ingredients, including vanillin and ethyl vanillin, natural vanillin, and some of its combinations; performance chemicals that include Hydroquinone (HQ), Catechol (CAT), Monomethyl Ether